SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

BGLC

Bionexus Gene Lab Corp.
NASDAQMaterials

Latest close: 1.20 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 7, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 14, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Jul 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year251
SEC filings on record15011 flagged findings
Reported transactions (Form 4)5since Aug 13, 2026 · and 8 other holdings
Corporate events (8-K)30since Jan 7, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-15bitcoin treasury exposurerecentOpen filing ↗
    “…implemented in phases, beginning with facility upgrades, equipment procurement, and quality management system enhancements aimed at…”
  • 2026-05-15business pivot to crypto/bitcoinrecentOpen filing ↗
    “…for our services; · the impact of government laws and regulations; · our ability to recruit and retain qualified personnel; · our…”
  • 2026-05-15share offering or dilution eventrecentOpen filing ↗
    “…into an Equity Distribution Agreement (the “Agreement”) with Maxim Group LLC (the “Agent”), pursuant to which the Company may…”
    +1 more passage from the same document
    • “…be “at-the-market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended, which may be made directly on The…”
  • 2026-05-15reverse splitrecentOpen filing ↗
    “…deficit ( 6,970,802 ) ( 6,427,227 ) Accumulated other comprehensive losses ( 98,849 ) ( 120,749 ) TOTAL STOCKHOLDERS’ EQUITY…”
    +1 more passage from the same document
    • “…AND STOCKHOLDERS’ EQUITY $ 9,040,130 $ 9,252,784 * Issued and outstanding shares of common stock have been adjusted as below:…”
  • 2026-04-14bitcoin treasury exposurerecentOpen filing ↗
    “…governance controls, updating approval workflows, and reviewing subsidiary-level delegations of authority. These steps are…”
    +1 more passage from the same document
    • “…the US “Crypto Strategic Reserve.” The Company published its “Ethereum Strategy Whitepaper” on that same date, which is available…”
  • 2026-04-14business pivot to crypto/bitcoinrecentOpen filing ↗
    “…officers. Cybersecurity and Digital Assets Integration On March 5, 2025, the Company announced its Ethereum-focused treasury…”
  • 2026-04-14share offering or dilution eventrecentOpen filing ↗
    “…Company concurrently entered into an Equity Distribution Agreement with Maxim Group LLC (“Agent”), pursuant to which the Company may…”
    +1 more passage from the same document
    • “…be “at-the-market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended, which may be made directly on The…”
  • 2026-04-14listing compliance noticerecentOpen filing ↗
    “…stock split proposal was necessary for the Company to maintain its Nasdaq listing (See B. Nasdaq Deficiency below). B. Nasdaq…”
    +1 more passage from the same document
    • “…the Dissident Actors ostensibly urged a number of shareholders holding a substantial number of votes to oppose the Compromised…”

2 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 150)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 7, 268-K ↗Current report · Entered a material agreement
  • Aug 14, 26SCHEDULE 13D ↗Stake with intent to influence · Tan Lee Su-Leng · 11.5% · event on Aug 13, 26
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Aug 14, 2610-Q ↗Quarterly report
  • Insider transaction · 6 Form 3 filingsshow all 6hide
  • Jul 28, 268-K ↗Current report · Other events
  • Jun 5, 268-K ↗Current report · Other events
  • May 15, 2610-Q ↗Quarterly report
  • Apr 14, 2610-K ↗Annual report
  • Mar 31, 26NT 10-K ↗Late filing notice
  • Mar 17, 268-K ↗Current report · Communication to the market · Other events
  • Feb 23, 268-K ↗Current report · Other events
  • Feb 3, 268-K ↗Current report · Other events
  • Dec 30, 258-K ↗Current report · Shareholder vote results
  • Dec 23, 258-K ↗Current report · Other events
  • Dec 3, 25DEF 14A ↗Shareholder meeting and votes

150 filings on record, the oldest from Jan 29, 19.

Listing the 25 most recent filings of the 150 on record.

8-Ks, explained

Stress5Structure17Governance14
  • Structure4 material agreements entered2025 – 2026show all 4hide
    • Oct 7, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Dec 2, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Nov 13, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Nov 12, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jun 23, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 30, 25StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Feb 14, 25StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Jan 2, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 8, 24StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Oct 15, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 25, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 26, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jul 5, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K/A 5.02 ↗
  • May 9, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 1, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗

10 older filings not shown · The record reaches back to Oct 15, 19.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 5 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).

Stock compensation, tax and giftsshow the 5 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 13, 26Compensationamount n/aJook Yuen Low↗
  • Aug 13, 26Compensationamount n/aSet Fui ChongChief Financial Officer↗
  • Aug 13, 26Compensationamount n/aAbdul Hamid Muhammad Azrul Bin↗
  • Aug 13, 26Compensationamount n/aChee Keong Yap↗
  • Aug 13, 26Compensationamount n/aLee Su-Leng TanChief Executive Officer↗

The full record holds 5 transactions and goes back to Mar 7, 22.

Its sector and its market

Bionexus Gene Lab Corp. among Materials companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Bionexus Gene Lab Corp., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Bionexus Gene Lab Corp. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
251 clean closes in the period.
SEC records
150 documents on file, from Jan 29, 2019 to Oct 7, 2026.
Company description
No description available.
This page
Generated on Oct 17, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.